TetraLogic Pharmaceuticals Corporation (TLOG)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jan 21, 2025, 4:00 PM EST

TLOG Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2015 FY 2014 FY 2013 FY 2012 FY 2011
Period Ending
Sep '16 Dec '15 Dec '14 Dec '13 Dec '12 Dec '11
Selling, General & Admin
9.3811.110.937.474.083.62
Research & Development
11.9127.420.299.5212.115.25
Operating Expenses
21.2938.531.2116.9916.1718.87
Operating Income
-21.29-38.5-31.21-16.99-16.17-18.87
Interest Expense
-6.8-6.38-3.36-2.77-0.07-0.01
Interest & Investment Income
0.050.10.11000
Other Non Operating Income (Expenses)
0.392.371.070.810.04-0.05
EBT Excluding Unusual Items
-27.65-42.41-33.39-18.95-16.2-18.92
Impairment of Goodwill
-16.9-16.9----
Gain (Loss) on Sale of Investments
--0---
Other Unusual Items
10.349.59-2.57-1--
Pretax Income
-43.04-49.72-35.96-19.95-16.2-18.92
Net Income
-40.72-49.72-35.96-19.95-16.2-18.92
Preferred Dividends & Other Adjustments
---3.253.453.27
Net Income to Common
-40.72-49.72-35.96-23.2-19.65-22.19
Shares Outstanding (Basic)
252422211
Shares Outstanding (Diluted)
252422211
Shares Change (YoY)
7.35%6.17%873.66%136.66%18.45%-
EPS (Basic)
-1.64-2.10-1.61-10.11-20.26-27.10
EPS (Diluted)
-1.65-2.10-1.63-10.11-20.26-27.10
Free Cash Flow
-23.88-34.97-32.88-12.84-15.96-17.35
Free Cash Flow Per Share
-0.96-1.47-1.47-5.59-16.45-21.18
EBITDA
-21.14-38.31-31.09-16.89-16.02-18.65
D&A For EBITDA
0.150.190.130.10.150.21
EBIT
-21.29-38.5-31.21-16.99-16.17-18.87
Source: S&P Capital IQ. Standard template. Financial Sources.